ANI Pharmaceuticals, Inc. (ANIP) Financials

ANIP Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 904.4 million 471.7 million
2023-09-30 889.9 million 435.2 million
2023-06-30 859.3 million 424.9 million
2023-03-31 765.2 million 425.7 million

ANIP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 40.0 million 5.6 million
2023-09-30 27.6 million 5.4 million
2023-06-30 13.8 million 5.2 million
2023-03-31 19.1 million 4.3 million

ANIP Net Income

No data available :(

ANIP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 221.1 million - -
2023-09-30 193.1 million - -
2023-06-30 161.7 million - -
2023-03-31 67.8 million - -

ANIP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 19.2 million
2023-09-30 19.1 million
2023-06-30 17.9 million
2023-03-31 16.5 million

ANIP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 4.8 million 9.9 million 44.5 million -
2023-09-30 4.6 million 11.1 million 42.0 million -
2023-06-30 6.8 million 7.4 million 38.8 million -
2023-03-31 2.4 million 5.9 million 37.4 million -

ANIP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 131.7 million 68.6 million
2023-09-30 131.8 million 48.1 million
2023-06-30 116.5 million 42.3 million
2023-03-31 106.8 million 37.7 million

ANIP

Price: $67.25

52 week price:
36.99
70.81

Earnings Per Share: 0.85 USD

P/E Ratio: 108.78

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 67658

Ebitda: 16.4 million

Market Capitalization: 1.4 billion

Links: